DarioHealth (DRIO) Stock Statistics & Valuation Metrics

DarioHealth has a market cap or net worth of $20.02M. The enterprise value is $42.70M.

DarioHealth has 45,496,956 shares outstanding. The number of shares has decreased by -2.65% in one year.

DarioHealth’s return on equity (ROE) is -0.59 and return on invested capital (ROIC) is -51.15%.

The current PE Ratio of DarioHealth is ―. DarioHealth’s PEG ratio is ―.

In the last 12 months, DarioHealth had revenue of 27.04M and earned -42.75M in profits. Earnings per share was 0.61.

In the last 12 months, operating cash flow was -26.79M and capital expenditures -128.00K, giving a free cash flow of -26.92M billion.

DarioHealth pays an annual dividend of ―, resulting in a dividend yield of ―

DarioHealth upcoming earnings date is Nov 17, 2025, Before Open (Confirmed).

DarioHealth as a current ratio of 2.44, with Debt / Equity ratio of 49.42%

In the past 12 months, DarioHealth has paid -1.85M in taxes.

DarioHealth EV to EBITDA ratio is -1.10, with an EV/FCF ratio of -1.43.

DarioHealth has $22.17M in cash and marketable securities with $31.62M in debt, giving a net cash position of $9.45M billion.

Gross margin is 54.98%, with operating margin of -213.55%, and net profit margin of -158.09%.

The average price target for DarioHealth is $0.93, which is 11.43% higher than the current price. The consensus rating is Moderate Buy